Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials (Q34542094)

2 August 2017

0 references

Methylxanthines for exacerbations of chronic obstructive pulmonary disease: meta-analysis of randomised trials (English)

1 reference

chronic obstructive pulmonary disease

2 August 2017

0 references

0 references

2

Brian H Rowe

1 reference

2 August 2017

3

Carlos A Camargo

1 reference

2 August 2017

1

R Graham Barr

1 reference

PubMed ID

14500434

2 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

2 August 2017

1 reference

2 August 2017

327

1 reference

2 August 2017

7416

1 reference

2 August 2017

643

1 reference

Oral theophylline for chronic obstructive pulmonary disease

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

7 July 2018

Theophylline in asthma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Rapid assay of serum theophylline levels

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Effects of theophylline on the course of hypercapnic respiratory insufficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Aminophylline Therapy for Acute Bronchospastic Disease in the Emergency Room

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

A double-blind comparison of a microcrystalline theophylline tablet and salbutamol in reversible airways obstruction

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

The effect of an oral aminophylline compound with protracted activity on respiratory resistance and blood gases in obstructive respiratory diseases (author's transl)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Therapeutic activities of theophylline in chronic obstructive pulmonary disease.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=196388

Comparison of intravenously administered doxofylline and placebo for the treatment of severe acute airways obstruction

27 October 2018

1 reference

12 December 2020

Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease

1 reference

12 December 2020

Theophylline and Salbutamol Improve Pulmonary Function in Patients with Irreversible Chronic Obstructive Pulmonary Disease

1 reference

12 December 2020

Theophylline target concentration in severe airways obstruction - 10 or 20 mg/L? A randomised concentration-controlled trial

1 reference

12 December 2020

Time and theophylline concentration help explain the recovery of peak flow following acute airways obstruction. Population analysis of a randomised concentration controlled trial

1 reference

12 December 2020

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society

1 reference

12 December 2020

BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS

1 reference

12 December 2020

[Increase of arterial oxygen pressure in therapy with theophylline in patients with obstructive ventilation disorder and partial respiratory insufficiency]

1 reference

12 December 2020

Comparison of the oral and intravenous routes for treating asthma with methylprednisolone and theophylline

1 reference

12 December 2020

Clinical trial of Theograd

1 reference

12 December 2020

Treatment of respiratory failure due to advanced chronic obstructive lung disease

1 reference

12 December 2020

[Clinical, functional and therapeutic aspects of chronic bronchitis and emphysema]

1 reference

12 December 2020

A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis

1 reference

12 December 2020

Theophylline serum concentration and therapeutic effect in severe acute bronchial obstruction: the optimal use of intravenously administered aminophylline

1 reference

12 December 2020

Maintenance of bronchodilation in chronic reversible airways obstruction. Comparison between choline theophyllinate and salbutamol

1 reference

12 December 2020

Intravenous aminophylline in the treatment of acute bronchospastic exacerbations of chronic obstructive pulmonary disease

1 reference

12 December 2020

Comparative study of the effects of intravenous administration of aminophylline, salbutamol and terbutaline in patients suffering and from reversible airways obstruction

1 reference

12 December 2020

A comparative trial of ipratropium bromide (Atrovent), controlled release theophylline (Phyllocontin), and a combination of these in patients with reversible airflow obstruction

1 reference

12 December 2020

Aminophylline for acute exacerbations of chronic obstructive pulmonary disease. A controlled trial

1 reference

12 December 2020

Comparative trials including a beta 2 adrenergic agonist, a methylxanthine, and a mast cell stabilizer

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.327.7416.643

1 reference

2 August 2017

1 reference

2 August 2017

1 reference

PubMed ID

14500434